April 30, 2018
Bristol-Myers Squibb and Otsuka Pharmaceuticals have reached settlement agreements with consumers in three cases scheduled for bellwether trials in Florida this summer in multidistrict litigation over side effects of the antipsychotic drug Abilify, according to a Saturday order.